🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is being conducted to evaluate how the body absorbs and processe...
Status
Completed
Location
Neuropsychiatric Research Institute
Start Date
2010-10
Trial ID
NCT01214382
Treatments Being Tested
The objective of this study was the bioequivalence of a Roxane Laboratories...
Status
Completed
Location
Anapharm Inc.
Start Date
2003-06
Trial ID
NCT00602849
Treatments Being Tested
To compare the rate of absorption and oral bioavailability of a test formul...
Status
Completed
Location
CEDRA Clinical Research, LLC
Start Date
2004-08
Trial ID
NCT00864344
Treatments Being Tested
The objective of this study was the bioequivalence of a Roxane Laboratories...
Status
Completed
Location
Anapharm Inc.
Start Date
2003-06
Trial ID
NCT00601588
Treatments Being Tested
The purpose of this study is to investigate the bioequivalence of ASC-01 Pl...
Status
Completed
Location
Osaka Pharmacology Clinical research Hospital
Start Date
2013-12
Trial ID
NCT02088697
The objective of this study was to investigate the bioequivalence of Mylan'...
Status
Completed
Location
Kendle International Inc.
Start Date
2002-12
Trial ID
NCT00648856
Treatments Being Tested
The objective of this study is to compare the rate and extent of absorption...
Status
Completed
Location
Anapharm Inc.
Start Date
2002-03
Trial ID
NCT00836849
Treatments Being Tested
To compare the rate of absorption and oral bioavailability of a test formul...
Status
Completed
Location
CEDRA Clinical Research, LLC
Start Date
2004-08
Trial ID
NCT00864019
Treatments Being Tested
The hypothesis of this study is that up to 150 mg of sertraline and up to 3...
Status
Completed
Location
Multiple Locations
Start Date
2010-05
Trial ID
NCT01155531
Treatments Being Tested
The objective of this study was to investigate the bioequivalence of Mylan'...
Status
Completed
Location
Kendle International Inc.
Start Date
2002-11
Trial ID
NCT00650325
Treatments Being Tested